Literature DB >> 7952919

Sex hormones and lipoprotein metabolism.

F M Sacks1, B W Walsh.   

Abstract

Previous findings of increased production of large VLDL particles by estrogen have been confirmed in a trial using estrogen-dominant oral contraceptives. Estrogen has been found to have LDL subclass-specific effects and to shift the distribution of apolipoprotein (apo)E from HDL to VLDL. Several recent studies document decreases in lipoprotein (a) [Lp(a)] levels, but the metabolic mechanism is yet unknown. The effects of progestational agents on lipoprotein metabolism remain unclear in view of conflicting reports.

Mesh：

Substances：

Year:  1994        PMID： 7952919     DOI： 10.1097/00041433-199405030-00012

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN： 0957-9672            Impact factor:   4.776


  9 in total

Review 1.  Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

Authors:  N C Inestrosa; M P Marzolo; A B Bonnefont
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

2.  Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study.

Authors:  E Koukkou; G F Watts; C Lowy
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

3.  Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype.

Authors:  Faidon Magkos; Elisa Fabbrini; B Selma Mohammed; Bruce W Patterson; Samuel Klein; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

Review 4.  Statins and menopause.

Authors:  Mohammed H Moghadasian
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

Review 6.  Maternal metabolism and obesity: modifiable determinants of pregnancy outcome.

Authors:  Scott M Nelson; Phillippa Matthews; Lucilla Poston
Journal:  Hum Reprod Update       Date:  2009-12-04       Impact factor: 15.610

7.  Effects of resistance training and detraining on muscle strength and blood lipid profiles in postmenopausal women.

Authors:  K J Elliott; C Sale; N T Cable
Journal:  Br J Sports Med       Date:  2002-10       Impact factor: 13.800

8.  HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study.

Authors:  Sara Sokooti; Jose L Flores-Guerrero; Lyanne M Kieneker; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

9.  Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies.

Authors:  Nathan W Kopper; Jennifer Gudeman; Daniel J Thompson
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.